Brief: Intec Pharma And Decoy Biosystems Announce Merger Agreement

Indaptus Therapeutics

15/03/2021 12:23

March 15 (Reuters) - Intec Pharma Ltd  NTEC.O :
    * INTEC PHARMA AND DECOY BIOSYSTEMS ANNOUNCE MERGER
AGREEMENT
    * INTEC PHARMA LTD - DECOY PLANS TO FILE AN IND IN H2 OF
2021 AND
TO INITIATE A PHASE I CLINICAL TRIAL IN 2022 TARGETING SOLID
TUMORS AND LYMPHOMAS
    * INTEC PHARMA - FORMER DECOY STOCKHOLDERS EXPECTED TO OWN
ABOUT
75% OF COMBINED CO, INTEC SHAREHOLDERS ARE EXPECTED TO OWN ABOUT
25% OF COMBINED CO
    * INTEC PHARMA LTD - COMBINED COMPANY IS EXPECTED TO BE LED
BY
JEFFREY MECKLER AS CEO AND MICHAEL NEWMAN AS CHIEF SCIENTIFIC
OFFICER

Source text for Eikon:  ID:nPn9D04csa 
Further company coverage:  NTEC.O 

 ((Reuters.Briefs@thomsonreuters.com;))